Company
Accession Therapeutics
making immuno-oncology therapeutics more targeted and potent than ever before
Also known as Accession Therapeutics Limited
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Oxford, United Kingdom
- Legal name
- Accession Therapeutics Limited
- accessiontherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
With its stealth virus platform technology, Trocept, Accession Therapeutics is focused on treating some of the most intractable and widespread forms of cancer.
Funding snapshot
- Total raised
- $40MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $40M2025-12-04
Funding rounds
- Round, 2025
- $40M2025-12-04, Company stated
Loading relationship preview